Nimbus Biotechnologie

Sovicell, formerly known as Nimbus Biotechnologie, is a German biotechnology company specializing in high-throughput ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicology) assays. The company is best known for its proprietary TRANSIL technology, a patented bead-based platform that mimics biological membranes and proteins to predict drug behavior in the human body. Sovicell provides ready-to-use kits and screening services for measuring critical pharmacokinetic parameters, such as plasma protein binding, membrane permeability, and blood-brain barrier penetration. Their products are designed to accelerate drug discovery by providing rapid, accurate, and reproducible data for both small molecules and peptides. Headquartered in Leipzig, Germany, the company serves a global clientele across the pharmaceutical and biotechnology sectors.